For the first time, we demonstrate that the Akt/NF-κB pathways may be involved in the expression of these molecules in HTNV-infected HUVECs, and cardamonin may serve as a potential, beneficial agent for HFRS therapy. The gene discussed is NFKB1; the disease is hemorrhagic fever with renal syndrome.